Disease | lipodystrophy |
Comorbidity | C0011603|dermatitis |
Sentences | 1 |
PubMedID- 22288582 | Despite the tremendous success of il-1 blocking therapy, the use of these agents in a wider spectrum of autoinflammatory conditions has uncovered disease subsets that are not responsive to il-1 blockade, including the recently discovered proteasome-associated autoinflammatory syndromes such as chronic atypical neutrophilic dermatitis with lipodystrophy and elevated temperatures (candle), japanese autoinflammatory syndrome with lipodystrophy (jasl), nakajo-nishimura syndrome (nns) and joint contractures, muscle atrophy, panniculitis induced lipodystrophy (jmp), and urge the continued quest to characterize additional dysregulated innate immune pathways that cause autoinflammatory conditions. |
Page: 1